NCT03462329 Patient's Pretreatment Expectations About Post-Lyme Symptoms
| NCT ID | NCT03462329 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Centre Ljubljana |
| Condition | Erythema Migrans |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2018-06-01 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2018-06-01 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment expectations quantified with a questionnaire and treatment outcome quantified with the presence of post-Lyme symptoms. Furthermore, the investigators will compare the prevalence of nonspecific symptoms among patients and among age-matched controls without a history of Lyme borreliosis.
Eligibility Criteria
Inclusion Criteria: * erythema migrans Exclusion Criteria: * pregnancy or lactation * immunocompromised * taking antibiotic with antiborrelial activity within 10 days
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03462329 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Erythema Migrans. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03462329 currently recruiting?
Yes, NCT03462329 is actively recruiting participants. Contact the research team at dasa.stupica@kclj.si for enrollment information.
Where is the NCT03462329 trial being conducted?
This trial is being conducted at Ljubljana, Slovenia.
Who is sponsoring the NCT03462329 clinical trial?
NCT03462329 is sponsored by University Medical Centre Ljubljana. The trial plans to enroll 200 participants.